Your browser doesn't support javascript.
Illness tracking in SARS-CoV-2 tested persons using a smartphone app: a non-interventional, prospective, cohort study.
Lovey, T; Bielecki, M; Gültekin, N; Stettbacher, A; Muggli, F; Stanga, Z; Farnham, A; Deuel, J; Schlagenhauf, P.
  • Lovey T; University of Zürich, Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, Zürich, Switzerland.
  • Bielecki M; University of Zürich, Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, Zürich, Switzerland.
  • Gültekin N; University Hospital of Zurich, Division of Infectious Diseases and Hospital Hygiene, Switzerland.
  • Stettbacher A; Swiss Armed Forces, Medical Services, Ittigen, Switzerland.
  • Muggli F; Swiss Armed Forces, Medical Services, Ittigen, Switzerland.
  • Stanga Z; Swiss Armed Forces, Medical Services, Monte Ceneri, Switzerland.
  • Farnham A; Swiss Armed Forces, Medical Services, Ittigen, Switzerland.
  • Deuel J; University of Zürich, Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, Zürich, Switzerland.
  • Schlagenhauf P; University of Zürich, Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, Zürich, Switzerland.
New Microbes New Infect ; 46: 100967, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1796255
ABSTRACT
There are few data on the range and severity of symptoms of SARS-CoV-2 infection or the impact on life quality in infected, previously healthy, young adults such as Swiss Armed Forces personnel. It is also unclear if an app can be used to remotely monitor symptoms in persons who test positive. Using a smartphone app called ITITP (Illness Tracking in Tested Persons) and weekly pop-up questionnaires, we aimed to evaluate the spectrum, duration, and impact of symptoms reported after a positive SARS-CoV-2 test according to sex, age, location, and comorbidities, and to compare these to responses from persons who tested negative. We followed up 502 participants (57% active participation), including 68 (13.5%) positive tested persons. Hospitalisation was reported by 6% of the positive tested participants. We found that positives reported significantly more symptoms that are typical of COVID-19 compared to negatives. These symptoms with odds ratio (OR > 1) were having difficulty breathing (OR 3.35; 95% CI 1.16, 9.65; p = 0.03), having a reduced sense of taste (OR 5.45; 95% CI 1.22, 24.34; p = 0.03) and a reduced sense of smell (OR 18.24; 95% CI 4.23, 78.69; p < 0.001). Using a random forest model, we showed that tiredness was the single symptom that was rated as having a significant impact on daily activities, whereas the other symptoms, although frequent, had less impact. The study showed that the use of an app was feasible to remotely monitor symptoms in persons infected with SARS-CoV-2 and could be adapted for other settings and new pandemic phases such as the current Omicron wave.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Language: English Journal: New Microbes New Infect Year: 2022 Document Type: Article Affiliation country: J.nmni.2022.100967

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Language: English Journal: New Microbes New Infect Year: 2022 Document Type: Article Affiliation country: J.nmni.2022.100967